PETA Buys Chimp Lab Stock

The animal rights organization purchases shares of a research facility in a bid to end chimpanzee testing at the facility.

By | December 22, 2011

Tanzanian chimpanzeeFLICKR, NILS RINALDI

People for the Ethical Treatment of Animals (PETA) has purchased stock of a Maryland-based private research facility BIOQUAL, which conducts tests on great apes. The animal rights organization plans to raise a resolution at the next shareholder’s meeting to end testing on chimpanzees, according to a press release from the organization.

BIOQUAL is currently testing a heptatitis C vaccine, and recently conducted research in the great apes using norovirus, which causes diarrhea, according to a press release. The action comes in the wake of last week’s Institute of Medicine report, which halted all new federal funding for chimpanzee research and found that most studies do not need to use the animals. The report’s writers were divided as to whether hepatitis C vaccine research should be allowed.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Can Plants Learn to Associate Stimuli with Reward?
  4. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

Business Birmingham